The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ACLARIS THERAPEUTICS INC | COM | 00461U105 | 1,620 | 1,500,000 | SH | SOLE | 1,500,000 | 0 | 0 | ||
| ALLERGAN PLC | SHS | G0177J108 | 235,623 | 1,400,101 | SH | SOLE | 1,400,101 | 0 | 0 | ||
| CHENIERE ENERGY INC | COM NEW | 16411R208 | 66,213 | 1,050,000 | SH | SOLE | 1,050,000 | 0 | 0 | ||
| CYCLERION THERAPEUTICS INC | COM | 23255M105 | 18,033 | 1,487,874 | SH | SOLE | 1,487,874 | 0 | 0 | ||
| EVOLUS INC | COM | 30052C107 | 1,874 | 120,000 | SH | SOLE | 120,000 | 0 | 0 | ||
| FGL HLDGS | ORD SHS | G3402M102 | 23,112 | 2,896,186 | SH | SOLE | 2,896,186 | 0 | 0 | ||
| FOX CORP | CL A COM | 35137L105 | 74,717 | 2,369,331 | SH | SOLE | 2,369,331 | 0 | 0 | ||
| GTT COMMUNICATIONS INC | COM | 362393100 | 9,242 | 981,143 | SH | SOLE | 981,143 | 0 | 0 | ||
| IRONWOOD PHARMACEUTICALS INC | COM CL A | 46333X108 | 55,283 | 6,439,541 | SH | SOLE | 6,439,541 | 0 | 0 | ||
| LIBERTY GLOBAL PLC | SHS CL C | G5480U120 | 71,370 | 3,000,000 | SH | SOLE | 3,000,000 | 0 | 0 | ||
| PG&E CORP | COM | 69331C108 | 28,000 | 2,800,000 | SH | SOLE | 2,800,000 | 0 | 0 | ||
| PIONEER NAT RES CO | COM | 723787107 | 33,140 | 263,500 | SH | SOLE | 263,500 | 0 | 0 | ||
| REVANCE THERAPEUTICS INC | COM | 761330109 | 598 | 46,000 | SH | SOLE | 46,000 | 0 | 0 | ||
| XPO LOGISTICS INC | COM | 983793100 | 50,099 | 700,000 | SH | SOLE | 700,000 | 0 | 0 | ||